What's new

Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Date of authorisation: 15/04/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Date of authorisation: 15/04/2025, Revision: 1, Status: Authorised

Jun 3, 2025 - 12:20
 0
Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Date of authorisation: 15/04/2025, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Date of authorisation: 15/04/2025, Revision: 1, Status: Authorised
Read More

Tags:

Previous Article

Hims & Hers looks to offer replica obesity drugs in UK and Europe

Next Article

UK Strategic Defence Review: Key Points from an Initial Reading

Related Posts

CHMP opinions on consultation procedures

CHMP opinions on consultation procedures

Jun 4, 2025  0

Human medicines European public assessment report (EPAR): Omjjara, momelotinib, Date of authorisation: 25/01/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

Guideline on core SmPC for human normal immunoglobulin ...

Jun 4, 2025  0